nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in the treatment of second-line non-small-cell lung cancer
|
Hanna, N. |
|
2005 |
50 |
S1 |
p. S15-S17 3 p. |
artikel |
2 |
A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabine
|
Natale, R. |
|
2005 |
50 |
S1 |
p. S2-S4 3 p. |
artikel |
3 |
Editorial
|
Belani, Chandra |
|
2005 |
50 |
S1 |
p. S1- 1 p. |
artikel |
4 |
Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabine
|
Choy, H. |
|
2005 |
50 |
S1 |
p. S10-S12 3 p. |
artikel |
5 |
Incorporating novel agents with gemcitabine-based treatment of NSCLC
|
Treat, Joseph |
|
2005 |
50 |
S1 |
p. S8-S9 2 p. |
artikel |
6 |
Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer
|
Scagliotti, G.V. |
|
2005 |
50 |
S1 |
p. S18-S19 2 p. |
artikel |
7 |
Perspective on the development of new agents in thoracic cancers
|
Einhorn, L. |
|
2005 |
50 |
S1 |
p. S27-S28 2 p. |
artikel |
8 |
Seeking improved outcome in the curative treatment of non-small-cell lung cancer
|
Vokes, Everett |
|
2005 |
50 |
S1 |
p. S20-S22 3 p. |
artikel |
9 |
Seeking new options for the treatment of small-cell lung cancer
|
Socinski, M.A. |
|
2005 |
50 |
S1 |
p. S25-S26 2 p. |
artikel |
10 |
Standard therapy for the treatment of malignant pleural mesothelioma
|
Vogelzang, Nicholas J. |
|
2005 |
50 |
S1 |
p. S23-S24 2 p. |
artikel |
11 |
The development of gemcitabine and carboplatin in the treatment of non-small-cell lung cancer
|
Cullen, M. |
|
2005 |
50 |
S1 |
p. S5-S7 3 p. |
artikel |
12 |
Using translational research to tailor the use of chemotherapy in the treatment of NSCLC
|
Bepler, Gerold |
|
2005 |
50 |
S1 |
p. S13-S14 2 p. |
artikel |